Cervical dysplasia treatment: key issues for developing countries
- PMID: 9041749
Cervical dysplasia treatment: key issues for developing countries
Abstract
Many developing countries face serious obstacles that have hindered establishment of successful cervical cancer control programs. Various countries are now seeking to strengthen cytology services and identify simple low-cost screening strategies; but any real gains in reducing cervical cancer incidence and mortality will also require effective treatment of women with preinvasive disease. Despite a trend toward conservative outpatient approaches for treating cervical dysplasia in industrialized countries, clinicians in many developing countries still rely primarily on invasive inpatient methods such as cone biopsy and hysterectomy. For women who could be treated with less invasive methods, these procedures tend to pose unnecessary risks and entail high costs that put them beyond the reach of many patients. Outpatient therapy, employing methods such as cryotherapy and the loop electrosurgical excision procedure (LEEP), combined with proper follow-up, is appropriate for dealing with visible lesions on the ectocervix when invasive cancer and endocervical involvement have been ruled out. Cryotherapy and LEEP hold out particular promise for developing countries because of their effectiveness, lack of side-effects, simplicity, and low cost. Cure rates range from 80% to 95%, depending on the method used and the severity of the lesions. However, each method has advantages and disadvantages that demand consideration. Various ways of reducing the number of follow-up visits, including the two-visit "see and treat" approach, are also available for use in areas where women's access to health services may be limited. A recent survey by the Program for Appropriate Technology in Health (PATH) affirmed the tendency to rely on cone biopsy and hysterectomy. It also found that in many places all degrees of preinvasive disease were treated, rather than only high-grade or severe conditions; that respondents in Latin America, the Caribbean, and Asia tended to use cryotherapy and LEEP more widely than other low-cost methods; that LEEP was preferred over cryotherapy in Latin America; and that colposcopes and other basic equipment needed to provide treatment were not consistently or widely available in some settings.
PIP: Financial, technical, and logistical factors have impeded the establishment of effective cervical cancer control programs in many developing countries. Efforts are now underway to strengthen cytology services and identify simple, inexpensive, alternative screening strategies that will improve early detection of cervical intraepithelial neoplasia (CIN). As part of this effort, the Program for Appropriate Technology in Health (PATH) surveyed the CIN treatment practices and preferences of 110 health practitioners from 33 developing countries. The survey revealed widespread reliance on invasive inpatient procedures such as cone biopsy and hysterectomy and a tendency to treat all preinvasive CIN, rather than only high-grade or severe CIN. Simple, low-cost, effective (80-95%) outpatient procedures such as cryotherapy and the loop electrosurgical excision procedure (LEEP) were selected more widely in Asia, the Caribbean, and Latin America than in Africa, but remained underutilized relative to inpatient treatments. In many settings, colposcopes and other basic equipment were not available. Respondents identified hysterectomy, cone biopsy, and LEEP as the most effective treatments of severe dysplasia. Overall, these findings suggest a need for more efficient use of scarce medical resources. Cryotherapy and LEEP, combined with proper follow-up, are particularly appropriate for developing countries in cases where invasive cancer and endocervical involvement have been ruled out.
Similar articles
-
Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial.JAMA. 2019 Oct 22;322(16):1570-1579. doi: 10.1001/jama.2019.14969. JAMA. 2019. PMID: 31638680 Free PMC article. Clinical Trial.
-
Colposcopy, cervicography, speculoscopy and endoscopy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.Acta Cytol. 1998 Jan-Feb;42(1):33-49. doi: 10.1159/000331533. Acta Cytol. 1998. PMID: 9479322 Review.
-
Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.PLoS One. 2018 Oct 11;13(10):e0203921. doi: 10.1371/journal.pone.0203921. eCollection 2018. PLoS One. 2018. PMID: 30308014 Free PMC article. Clinical Trial.
-
[Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].Zhonghua Fu Chan Ke Za Zhi. 2017 Nov 25;52(11):751-756. doi: 10.3760/cma.j.issn.0529-567X.2017.11.007. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 29179270 Chinese.
-
Performance of a colposcopic examination, a loop electrosurgical procedure, and cryotherapy of the cervix.Obstet Gynecol Clin North Am. 2013 Dec;40(4):731-57. doi: 10.1016/j.ogc.2013.08.008. Obstet Gynecol Clin North Am. 2013. PMID: 24286998 Review.
Cited by
-
Epidemiology of Cervical Cancer in the Caribbean.Cureus. 2023 Nov 3;15(11):e48198. doi: 10.7759/cureus.48198. eCollection 2023 Nov. Cureus. 2023. PMID: 38054120 Free PMC article. Review.
-
Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis.BMC Med Res Methodol. 2007 Jul 31;7:36. doi: 10.1186/1471-2288-7-36. BMC Med Res Methodol. 2007. PMID: 17663796 Free PMC article.
-
PrediQt-Cx: post treatment health related quality of life prediction model for cervical cancer patients.PLoS One. 2014 Feb 26;9(2):e89851. doi: 10.1371/journal.pone.0089851. eCollection 2014. PLoS One. 2014. PMID: 24587074 Free PMC article.
-
Vaginal Suppositories Containing SHetA2 to Treat Cervical Dysplasia: Pharmacokinetics of Daily Doses and Preliminary Safety Profile.J Pharm Sci. 2020 Jun;109(6):2000-2008. doi: 10.1016/j.xphs.2020.02.016. Epub 2020 Feb 27. J Pharm Sci. 2020. PMID: 32113976 Free PMC article.
MeSH terms
LinkOut - more resources
Research Materials